Sven Påhlman (Former)
1 – 50 of 105
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paraganglioma
(
- Contribution to journal › Article
- 2020
-
Mark
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Integrative discovery of treatments for high-risk neuroblastoma
(
- Contribution to journal › Article
-
Mark
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma
(
- Contribution to journal › Article
-
Mark
Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells
(
- Contribution to journal › Article
- 2019
-
Mark
ALK positively regulates MYCN activity through repression of HBP1 expression
(
- Contribution to journal › Article
- 2018
-
Mark
A Novel Topical PPAR 3 Agonist Induces PPAR 3 Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models
(
- Contribution to journal › Article
-
Mark
Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Promoter-associated proteins of EPAS1 identified by enChIP-MS – A putative role of HDX as a negative regulator
(
- Contribution to journal › Article
-
Mark
Hypoxia and hypoxia-inducible factors in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Refined control of cell stemness allowed animal evolution in the oxic realm
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells
(
- Contribution to journal › Article
-
Mark
Hypoxia and Cancer Stem Cell Regulation
2017) p.101-126(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Hypoxia, pseudohypoxia and cellular differentiation
(
- Contribution to journal › Article
-
Mark
Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum
(
- Contribution to journal › Article
-
Mark
No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(51). p.10856-10858(
- Contribution to journal › Letter
- 2016
-
Mark
HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells.
(
- Contribution to journal › Article
-
Mark
Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort
(
- Contribution to journal › Article
-
Mark
Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
(
- Contribution to journal › Scientific review
-
Mark
Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours
(
- Contribution to journal › Article
- 2015
-
Mark
Differential HIF-1α and HIF-2α Expression in Mammary Epithelial Cells during Fat Pad Invasion, Lactation, and Involution.
(
- Contribution to journal › Article
-
Mark
Differential regulation of HIF-1α and HIF-2α in neuroblastoma: Estrogen-related receptor alpha (ERRα) regulates HIF2A transcription and correlates to poor outcome.
(
- Contribution to journal › Article
-
Mark
PI3K-mTORC2 but not PI3K-mTORC1 Regulates Transcription of HIF2A/EPAS1 and Vascularization in Neuroblastoma.
(
- Contribution to journal › Article
-
Mark
The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.
(
- Contribution to journal › Article
-
Mark
Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use.
(
- Contribution to journal › Article
-
Mark
Neuroblastoma Patient-Derived Orthotopic Xenografts Retain Metastatic Patterns and Geno- and Phenotypes of Patient Tumours.
(
- Contribution to journal › Article
- 2014
-
Mark
Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.
(
- Contribution to journal › Article
-
Mark
TLX activates MMP-2, promotes self-renewal of tumor spheres in neuroblastoma and correlates with poor patient survival.
(
- Contribution to journal › Article
-
Mark
EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
(
- Contribution to journal › Article
-
Mark
The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner.
(
- Contribution to journal › Article
- 2013
-
Mark
Quantitative Proteomics Profiling of Primary Lung Adenocarcinoma Tumors Reveals Functional Perturbations in Tumor Metabolism
(
- Contribution to journal › Article
-
Mark
The tyrosine kinase CSK associates with FLT3 and c-Kit receptors and regulates downstream signaling.
(
- Contribution to journal › Article
-
Mark
MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells
(
- Contribution to journal › Article
-
Mark
HIF2A and IGF2 Expression Correlates in Human Neuroblastoma Cells and Normal Immature Sympathetic Neuroblasts.
(
- Contribution to journal › Article
-
Mark
snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.
(
- Contribution to journal › Article
- 2012
-
Mark
HIF-2α Expression Is Suppressed in SCLC Cells, Which Survive in Moderate and Severe Hypoxia When HIF-1α Is Repressed.
(
- Contribution to journal › Article
-
Mark
Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors.
(
- Contribution to journal › Article
-
Mark
Neuroblastoma: Role of hypoxia and hypoxia inducible factors in tumor progression
2012) 1st edition, XXVI.(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Hypoxic conditions induce a cancer-like phenotype in human breast epithelial cells.
(
- Contribution to journal › Article
-
Mark
Tumor-initiating cells in childhood neuroblastoma : Letter
(
- Contribution to journal › Letter
- 2011
-
Mark
Neuroblastoma research progress - A 2011 perspective
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage.
(
- Contribution to journal › Article
-
Mark
JAG2 induction in hypoxic tumor cells alters Notch signaling and enhances endothelial cell tube formation.
(
- Contribution to journal › Article
-
Mark
Hunting for Protein Markers of Hypoxia by Combining Plasma Membrane Enrichment with a New Approach to Membrane Protein Analysis
(
- Contribution to journal › Article
-
Mark
Prognostic Value of SOX2 Expression in Neuroblastoma
(
- Contribution to journal › Letter
-
Mark
High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer
(
- Contribution to journal › Article
- 2010
-
Mark
MYCN-regulated microRNAs repress estrogen receptor-{alpha} (ESR1) expression and neuronal differentiation in human neuroblastoma.
(
- Contribution to journal › Article
-
Mark
The HIF-2alpha-Driven Pseudo-Hypoxic Phenotype in Tumor Aggressiveness, Differentiation, and Vascularization.
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2009
-
Mark
HIF-1{alpha} and HIF-2{alpha} Are Differentially Regulated In vivo in Neuroblastoma: High HIF-1{alpha} Correlates Negatively to Advanced Clinical Stage and Tumor Vascularization.
(
- Contribution to journal › Article